Back to Search
Start Over
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.
- Source :
-
Annals of Oncology . Oct2018, Vol. 29 Issue 10, p2151-2151. 1p. - Publication Year :
- 2018
- Subjects :
- *GENETIC mutation
*BREAST cancer
*TRASTUZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 29
- Issue :
- 10
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 132935377
- Full Text :
- https://doi.org/10.1093/annonc/mdx803